메뉴 건너뛰기




Volumn 43, Issue 12, 2010, Pages 1003-1008

Development of a competitive radioimmunoassay for glypican-3 and the clinical application in diagnosis of hepatocellular carcinoma

Author keywords

AFP; Combined AFP CA19 9; Glypican 3; Hepatocellular carcinoma (HCC)

Indexed keywords

GLYPICAN 3; IODINE 125; TUMOR MARKER; GLYPICAN;

EID: 77954310523     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.04.074     Document Type: Article
Times cited : (38)

References (33)
  • 1
    • 28844480321 scopus 로고    scopus 로고
    • Management of hepatocellular carcinoma
    • Bruix J., Sherman M. Management of hepatocellular carcinoma. Hepatology 2005, 42:1208-1236.
    • (2005) Hepatology , vol.42 , pp. 1208-1236
    • Bruix, J.1    Sherman, M.2
  • 2
    • 0033638414 scopus 로고    scopus 로고
    • Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring
    • Dufour D.R., Lott J.A., Nolte F.S., Gretch D.R., Koff R.S., Seeff L.B. Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin Chem 2000, 46:2050-2068.
    • (2000) Clin Chem , vol.46 , pp. 2050-2068
    • Dufour, D.R.1    Lott, J.A.2    Nolte, F.S.3    Gretch, D.R.4    Koff, R.S.5    Seeff, L.B.6
  • 3
  • 4
    • 0037407560 scopus 로고    scopus 로고
    • Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults
    • Ryder S.D. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut 2003, 52:1-8.
    • (2003) Gut , vol.52 , pp. 1-8
    • Ryder, S.D.1
  • 5
    • 77954314841 scopus 로고    scopus 로고
    • National Academy of clinical biochemistry guidelines for the use of tumor markers in primary liver cancer.
    • Lamerz R, Hayes P, Hoffmann RT, Löhe F, Shiratori Y, Taketa K. National Academy of clinical biochemistry guidelines for the use of tumor markers in primary liver cancer 2003, http://www.nacb.org/lmpg/tumor/chp3d_liver.pdf.
    • (2003)
    • Lamerz, R.1    Hayes, P.2    Hoffmann, R.T.3    Löhe, F.4    Shiratori, Y.5    Taketa, K.6
  • 6
    • 0027243462 scopus 로고
    • Risk factors for hepatocellular carcinoma among patients with chronic liver disease
    • Tsukuma H., Hiyama T., Tanaka S., Nakao M., Yabuuchi T., Kitamura T., et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993, 328:1797-1801.
    • (1993) N Engl J Med , vol.328 , pp. 1797-1801
    • Tsukuma, H.1    Hiyama, T.2    Tanaka, S.3    Nakao, M.4    Yabuuchi, T.5    Kitamura, T.6
  • 7
    • 34548488009 scopus 로고    scopus 로고
    • AFP-L3 in chronic liver diseases with persistent elevation of alpha-fetoprotein
    • Cheng H.T., Chang Y.H., Chen Y.Y., Lee T.H., Tai D.I., Lin D.Y. AFP-L3 in chronic liver diseases with persistent elevation of alpha-fetoprotein. J Chin Med Assoc 2007, 70:310-317.
    • (2007) J Chin Med Assoc , vol.70 , pp. 310-317
    • Cheng, H.T.1    Chang, Y.H.2    Chen, Y.Y.3    Lee, T.H.4    Tai, D.I.5    Lin, D.Y.6
  • 8
    • 49849106705 scopus 로고    scopus 로고
    • Glycomic analysis of alpha-fetoprotein L3 in hepatoma cell lines and hepatocellular carcinoma patients
    • Nakagawa T., Miyoshi E., Yakushijin T., Hiramatsu N., Igura T., Hayashi N., et al. Glycomic analysis of alpha-fetoprotein L3 in hepatoma cell lines and hepatocellular carcinoma patients. J Proteome Res 2008, 7:2222-2233.
    • (2008) J Proteome Res , vol.7 , pp. 2222-2233
    • Nakagawa, T.1    Miyoshi, E.2    Yakushijin, T.3    Hiramatsu, N.4    Igura, T.5    Hayashi, N.6
  • 9
    • 30644467109 scopus 로고    scopus 로고
    • Usefulness of serum des-γ-carboxy prothrombin in detection of hepatocellular carcinoma
    • Wang C.S., Lin C.L., Lee H.C., Chen K.Y., Chiang M.F., Chen H.S., et al. Usefulness of serum des-γ-carboxy prothrombin in detection of hepatocellular carcinoma. World J Gastroenterol 2005, 11:6115-6119.
    • (2005) World J Gastroenterol , vol.11 , pp. 6115-6119
    • Wang, C.S.1    Lin, C.L.2    Lee, H.C.3    Chen, K.Y.4    Chiang, M.F.5    Chen, H.S.6
  • 10
    • 61749103943 scopus 로고    scopus 로고
    • The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma
    • Tommaso L.D., Destro A., Seok J.Y., Balladore E., Terracciano L., Sangiovanni A., et al. The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma. J Hepatol 2009, 50:746-754.
    • (2009) J Hepatol , vol.50 , pp. 746-754
    • Tommaso, L.D.1    Destro, A.2    Seok, J.Y.3    Balladore, E.4    Terracciano, L.5    Sangiovanni, A.6
  • 12
    • 62849103665 scopus 로고    scopus 로고
    • Significance of serum tumor markers carcinoembryonic antigen, CA19-9, CA 125, and CA 15-3 in pre-orthotopic liver transplantation evaluation
    • Pissaia A., Bernard J.D., Scatton O., Soubrane O., Conti F., Calmus Y. Significance of serum tumor markers carcinoembryonic antigen, CA19-9, CA 125, and CA 15-3 in pre-orthotopic liver transplantation evaluation. Transplant Proc 2009, 41:682-684.
    • (2009) Transplant Proc , vol.41 , pp. 682-684
    • Pissaia, A.1    Bernard, J.D.2    Scatton, O.3    Soubrane, O.4    Conti, F.5    Calmus, Y.6
  • 13
    • 0344069531 scopus 로고    scopus 로고
    • Differential tumor markers and hepatitis markers profile in liver tumors
    • Khalifa A., Mady E.A., Abadeer N., Kamal A. Differential tumor markers and hepatitis markers profile in liver tumors. Anticancer Res 1999, 19:2495-2500.
    • (1999) Anticancer Res , vol.19 , pp. 2495-2500
    • Khalifa, A.1    Mady, E.A.2    Abadeer, N.3    Kamal, A.4
  • 14
    • 0026877124 scopus 로고
    • Hepatocellular carcinoma producing carcinoembryonic antigen and carbohydrate antigen 19-9
    • Usui Y., Miura H., Kimura Y., Takayama S., Nakayama M. Hepatocellular carcinoma producing carcinoembryonic antigen and carbohydrate antigen 19-9. Intern Med 1992, 31:791-793.
    • (1992) Intern Med , vol.31 , pp. 791-793
    • Usui, Y.1    Miura, H.2    Kimura, Y.3    Takayama, S.4    Nakayama, M.5
  • 15
    • 0034893110 scopus 로고    scopus 로고
    • Glypicans: proteoglycans with a surprise
    • Filmus J., Selleck S.B. Glypicans: proteoglycans with a surprise. J Clin Invest 2001, 108:497-501.
    • (2001) J Clin Invest , vol.108 , pp. 497-501
    • Filmus, J.1    Selleck, S.B.2
  • 17
    • 77954314730 scopus 로고    scopus 로고
    • Methods for diagnosing and treating prostate cancer, US Patent 20070154964.
    • Wang B, Wab M. Methods for diagnosing and treating prostate cancer, US Patent 20070154964.
    • Wang, B.1    Wab, M.2
  • 20
    • 0038054270 scopus 로고    scopus 로고
    • Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker
    • Tetsuya N., Yoshihiro Y., Satoru S., Mikio M., Hiroyuki K., Yutaka M., et al. Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker. Biochem Biophys Res Commun 2003, 306:16-25.
    • (2003) Biochem Biophys Res Commun , vol.306 , pp. 16-25
    • Tetsuya, N.1    Yoshihiro, Y.2    Satoru, S.3    Mikio, M.4    Hiroyuki, K.5    Yutaka, M.6
  • 21
    • 0035086268 scopus 로고    scopus 로고
    • Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders
    • Zhu Z.W., Friess H., Wang L., Abou-Shady M., Zimmermann A., Lander A.D., et al. Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders. Gut 2001, 48:558-564.
    • (2001) Gut , vol.48 , pp. 558-564
    • Zhu, Z.W.1    Friess, H.2    Wang, L.3    Abou-Shady, M.4    Zimmermann, A.5    Lander, A.D.6
  • 22
    • 27944433471 scopus 로고    scopus 로고
    • The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma
    • Yamauchi N., Watanabe A., Hishinuma M., Ohashi K.I., Midorikawa Y., Morishita Y., et al. The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma. Mod Pathol 2005, 18:1591-1598.
    • (2005) Mod Pathol , vol.18 , pp. 1591-1598
    • Yamauchi, N.1    Watanabe, A.2    Hishinuma, M.3    Ohashi, K.I.4    Midorikawa, Y.5    Morishita, Y.6
  • 23
    • 0034688147 scopus 로고    scopus 로고
    • Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma
    • Murthy S.S., Shen T., De Rienzo A., Lee W.C., Ferriola P.C., Jhanwar S.C., et al. Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma. Oncogene 2000, 19:410-416.
    • (2000) Oncogene , vol.19 , pp. 410-416
    • Murthy, S.S.1    Shen, T.2    De Rienzo, A.3    Lee, W.C.4    Ferriola, P.C.5    Jhanwar, S.C.6
  • 24
    • 0035504922 scopus 로고    scopus 로고
    • Glypican-3 expression is silenced in human breast cancer
    • Xiang Y.Y., Ladeda V., Filmus J. Glypican-3 expression is silenced in human breast cancer. Oncogene 2001, 20:7408-7412.
    • (2001) Oncogene , vol.20 , pp. 7408-7412
    • Xiang, Y.Y.1    Ladeda, V.2    Filmus, J.3
  • 26
    • 0036064793 scopus 로고    scopus 로고
    • Glypican-3 expression is markedly decreased in human gastric cancer but not in esophageal cancer
    • Zhu Z., Friess H., Kleeff J., Wang L., Wirtz M., Zimmermann A., et al. Glypican-3 expression is markedly decreased in human gastric cancer but not in esophageal cancer. Am J Surg 2002, 184:78-83.
    • (2002) Am J Surg , vol.184 , pp. 78-83
    • Zhu, Z.1    Friess, H.2    Kleeff, J.3    Wang, L.4    Wirtz, M.5    Zimmermann, A.6
  • 27
    • 0033557918 scopus 로고    scopus 로고
    • Frequent silencing of the GPC3 gene in ovarian cancer cell lines
    • Lin H., Huber R., Schlessinger D., Morin P.J. Frequent silencing of the GPC3 gene in ovarian cancer cell lines. Cancer Res 1999, 59:807-810.
    • (1999) Cancer Res , vol.59 , pp. 807-810
    • Lin, H.1    Huber, R.2    Schlessinger, D.3    Morin, P.J.4
  • 30
    • 11244326977 scopus 로고    scopus 로고
    • Glypican-3 as a serum marker for hepatocellular carcinoma
    • Capurro M., Filmus J. Glypican-3 as a serum marker for hepatocellular carcinoma. Cancer Res 2005, 65:372-373.
    • (2005) Cancer Res , vol.65 , pp. 372-373
    • Capurro, M.1    Filmus, J.2
  • 31
    • 27244454806 scopus 로고    scopus 로고
    • Mechanisms of heat-induced antigen retrieval: does pH or ionic strength of the solution play a role for refolding antigens
    • Emoto K., Yamashita S., Okada Y. Mechanisms of heat-induced antigen retrieval: does pH or ionic strength of the solution play a role for refolding antigens. J Histochem Cytochem 2005, 53:1311-1321.
    • (2005) J Histochem Cytochem , vol.53 , pp. 1311-1321
    • Emoto, K.1    Yamashita, S.2    Okada, Y.3
  • 32
    • 0028204881 scopus 로고
    • Noncompetitive immunoassay of thyroxine using a liquid-phase binding assay
    • Hara T., Nakamura K., Satomura S., Matsuura S. Noncompetitive immunoassay of thyroxine using a liquid-phase binding assay. Anal Chem 1994, 66:351-354.
    • (1994) Anal Chem , vol.66 , pp. 351-354
    • Hara, T.1    Nakamura, K.2    Satomura, S.3    Matsuura, S.4
  • 33
    • 33947396135 scopus 로고    scopus 로고
    • Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis
    • Tommaso L.D., Franchi G., Park Y.N., Fiamengo B., Destro A., Morenghi E., et al. Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis. Hepatology 2007, 45:725-734.
    • (2007) Hepatology , vol.45 , pp. 725-734
    • Tommaso, L.D.1    Franchi, G.2    Park, Y.N.3    Fiamengo, B.4    Destro, A.5    Morenghi, E.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.